DHC Share Price Performance
US$4.74
2.19 (85.88%)
5.3% overvalued intrinsic discount
US$4.50
Fair Value
Price US$4.74
AnalystHighTarget US$4.50
AnalystConsensusTarget US$5.25
AnalystLowTarget US$3.00
Fair ValueUS$4.50
Share Pricen/a
Diversified Healthcare Trust Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
DHC Community Narratives
AN
Fair Value US$4.5 5.3% overvalued intrinsic discount
Aging Populations And Telehealth Trends Will Uplift Facilities
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$5.25 9.7% undervalued intrinsic discount
Aging US Population And Outpatient Care Demand Will Transform Markets
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value US$3 58.0% overvalued intrinsic discount
Elevated Debt And Regulatory Pressure Will Weaken Senior Housing
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Aging US Population And Outpatient Care Demand Will Transform Markets
Key Takeaways Strong demand in senior housing and medical office assets, along with operational improvements, is boosting revenue growth and margin expansion. Strategic asset sales, capital redeployment, and debt refinancing are lowering leverage while enhancing cash flow stability and long-term shareholder value.Read more
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$5.25
9.7% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
2.06% p.a.
Profit Margin
24.52%
Future PE
4.38x
Share price in 2028
US$7.17
Aging Populations And Telehealth Trends Will Uplift Facilities
Key Takeaways Divesting underperforming assets and repositioning towards higher-quality properties is set to rapidly improve portfolio quality, margins, and long-term revenue growth. Strategic refinancing, favorable demographic trends, and robust institutional investor interest are expected to drive sustainable earnings upside and support long-term asset value appreciation.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$4.5
5.3% overvalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
2.84% p.a.
Profit Margin
23.33%
Future PE
3.89x
Share price in 2028
US$6.21
Elevated Debt And Regulatory Pressure Will Weaken Senior Housing
Key Takeaways Heavy debt burden, rising interest expenses, and limited capital access threaten profitability, reinvestment capacity, and overall financial stability. Shifts in healthcare delivery and persistent tenant weakness undermine occupancy and revenue growth across core facility assets.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$3
58.0% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
2.24% p.a.
Profit Margin
23.33%
Future PE
2.68x
Share price in 2028
US$4.2
Recently Updated Narratives
AN
Aging US Population And Outpatient Care Demand Will Transform Markets
Fair Value: US$5.25 9.7% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Aging Populations And Telehealth Trends Will Uplift Facilities
Fair Value: US$4.5 5.3% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Elevated Debt And Regulatory Pressure Will Weaken Senior Housing
Fair Value: US$3 58.0% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Diversified Healthcare Trust Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -1.45
- 17.49%
- -22.90%
- 161.2%
About DHC
- Founded
- 1998
- Employees
- n/a
- CEO
- WebsiteView website
DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of September 30, 2025, DHC’s approximately $6.7 billion portfolio included 335 properties in 34 states and Washington, D.C., with more than 26,000 senior living units, approximately 6.9 million square feet of medical office and life science properties and occupied by approximately 420 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with approximately $39 billion in assets under management as of September 30, 2025 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA.
